Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (right eye)
ICD-10 E10.3411 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (right eye).
E10.3411 refers to a specific complication of Type 1 diabetes mellitus characterized by severe nonproliferative diabetic retinopathy (NPDR) with macular edema in the right eye. Type 1 diabetes is an autoimmune condition where the pancreas produces little to no insulin, leading to elevated blood glucose levels. Over time, chronic hyperglycemia can cause damage to the retinal blood vessels, resulting in NPDR, which is marked by retinal hemorrhages, exudates, and microaneurysms. The presence of macular edema indicates fluid accumulation in the macula, the central part of the retina responsible for sharp vision, which can lead to significant visual impairment. Management of this condition often involves strict glycemic control, regular ophthalmologic evaluations, and may include treatments such as laser therapy or intravitreal injections to reduce edema and prevent further vision loss. The severity of the retinopathy and the presence of macular edema necessitate careful monitoring and intervention to preserve vision and manage diabetes effectively.
Comprehensive records of diabetes management, including HbA1c levels, insulin regimen, and patient education.
Patients presenting with uncontrolled diabetes, requiring insulin adjustments or new treatment plans.
Endocrinologists must document the patient's overall diabetes management and any referrals to ophthalmology.
Detailed findings from eye examinations, including retinal imaging and assessments of macular edema.
Patients with visual complaints related to diabetic retinopathy requiring intervention.
Ophthalmologists should ensure clarity in documenting the severity of retinopathy and any treatments provided.
Used for treating macular edema in patients with diabetic retinopathy.
Document indication for injection, patient consent, and follow-up plans.
Ophthalmologists must ensure proper coding based on the specific treatment provided.
Coding E10.3411 accurately reflects the severity of diabetic retinopathy and ensures appropriate management and treatment plans are in place for patients with Type 1 diabetes.
